IP Library › Granted Patent US 10,308,615

Granted Patent B2

US 10,308,615 · App. 15/574,625 · Granted Jun 4, 2019

Heterocyclic compounds as inhibitors of Vanin-1 enzyme

Inventors: Agustin Casimiro-Garcia (Concord, MA); Jeffrey Scott Condon (Melrose, MA); Andrew Christopher Flick (East Lyme, CT); Ariamala Gopalsamy (Lexington, MA); Steven J. Kirincich (Concord, MA); John Paul Mathias (Concord, MA); Joseph Walter Strobach (Wentzville, MO); Jason Shaoyun Xiang (Winchester, MA); Li Huang Xing (Lexington, MA); Xiaolun Wang (San Diego, CA)

Assignee: Pfizer Inc.

C07D239/42 A61K31/505 A61P1/00 A61P1/04 A61P35/00 C07D239/28 C07D241/14 C07D401/12 C07D403/12 C07D405/10

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 10,308,615
App. No.: 15/574,625
Granted: Jun 4, 2019
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

Compounds, pharmaceutically acceptable salts thereof, are disclosed wherein the compounds have the structure of as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Claims (244)

1. A compound of Formula I:

or a pharmaceutically acceptable salt thereof, wherein

A 1 is C(R 3 ), A 2 is N and A 3 is C(R 3 );

R 1 is selected from the group consisting of:

(i) 6 to 10 membered aryl optionally substituted with one, two, three or four E; and

(ii) 5 to 11 membered heteroaryl optionally substituted with one, two, three or four E, wherein said 5 to 11 membered heteroaryl (a) comprises one, two or three heteroatoms independently selected for each occurrence from the group consisting of —N═, —N(J)-, —O—, and —S— and (b) is not bound to the carbonyl of Formula (I) through a nitrogen;

W is selected from the group consisting of:

(i) —NHCG 2 -R 2 ;

(ii) —NHCG 2 CG 2 -R 2 ;

(iii) —OCG 2 -R 2 ;

(iv) —OCG 2 CG 2 -R 2 ;

R 2 is selected from the group consisting of:

(i) phenyl optionally substituted with one, two, three or four E; and

(ii) 5 to 6 membered heteroaryl optionally substituted with one, two, three or four E, wherein said 5 to 6 membered heteroaryl comprises one or two heteroatoms independently selected for each occurrence from the group consisting of —N═, —N(J)-, —O—, and —S—;

(iii) —C 3 -C 7 carbocyclyl optionally substituted with one, two, three, four, five or six E;

(iv) 4 to 7 membered heterocyclyl optionally substituted with one, two, three, four, five or six E, wherein said 4 to 7 membered heterocyclyl comprises one or two heteroatoms independently selected for each occurrence from the group consisting of —N(J)-, —O— and —S—; and

(v) 4 to 7 membered heterocyclyl optionally substituted with one, two, three, four, five or six E, wherein said 4 to 7 membered heterocyclyl is (i) bound to W through a first heterocyclyl ring heteroatom —N— and (ii) which optionally comprises a second ring heteroatom independently selected from the group consisting of —N(J)-, —O—, and —S—;

R 3 is independently selected for each occurrence from the group consisting of —H, —F, —Cl, —CN, —CH 3 , —CH 2 CH 3 , —CH 2 F, —CHF 2 , —CF 3 , —CF 2 CF 3 , —OCH 3 , —OCH 2 F, —OCHF 2 , —OCF 3 , —SCH 3 , —SCH 2 F, —SCHF 2 , and —SCF 3 ;

E is independently selected for each occurrence from the group consisting of:

(i) —H;

(ii) —halo;

(iii) —CN;

(iv) —OH;

(v) —CO 2 H;

(vi) —C 1 -C 6 alkyl optionally substituted with one, two, three, four, five or six K;

(vii) —OC 1 -C 6 alkyl optionally substituted with one, two, three, four, five or six K;

(viii) —SC 1 -C 6 alkyl optionally substituted with one, two, three, four, five or six K;

(ix) —C 3 -C 5 cycloalkyl optionally substituted with one, two, three, four, five or six K;

(x) —OC 3 -C 5 cycloalkyl optionally substituted with one, two, three, four, five or six K;

(xi) —SC 3 -C 5 cycloalkyl optionally substituted with one, two, three, four, five or six K;

(xii) —C 1 -C 6 alkyl(C 3 -C 5 cycloalkyl) optionally substituted with one, two, three, four, five or six K;

(xiii) 4 to 7 membered heterocyclyl optionally substituted with one, two, three, four, five or six K, wherein said 4 to 7 membered heterocyclyl comprises one or two heteroatoms independently selected for each occurrence from the group consisting of —N(J)-, —O— or —S—;

(xiv) —NH 2 ;

(xv) —NH(C 1 -C 6 alkyl), which C 1 -C 6 alkyl is optionally substituted with one, two, three, four, five or six K;

(xvi) —N(C 1 -C 6 alkyl) 2 , which C 1 -C 6 alkyl is, independently for each occurrence, optionally substituted with one, two, three, four, five or six K;

(xvii) —C(O)NH 2 ;

(xviii) —C(O)NH(C 1 -C 6 alkyl), which C 1 -C 6 alkyl is optionally substituted with one, two, three, four, five or six K;

(xix) —C(O)N(C 1 -C 6 alkyl) 2 , which C 1 -C 6 alkyl is, independently for each occurrence, optionally substituted with one, two, three, four, five or six K;

(xx) —NHC(O)(C 1 -C 6 alkyl), which C 1 -C 6 alkyl is optionally substituted with one, two, three, four, five or six K;

(xxi) —N(C 1 -C 6 alkyl)C(O)(C 1 -C 6 alkyl), which C 1 -C 6 alkyl is, independently for each occurrence, optionally substituted with one, two, three, four, five or six K;

(xxii) —SO 2 (C 1 -C 6 alkyl), which C 1 -C 6 alkyl is optionally substituted with one, two, three, four, five or six K;

(xxiii) —SO 2 NH 2 ;

(xxiv) —SO 2 NH(C 1 -C 6 alkyl), which C 1 -C 6 alkyl is optionally substituted with one, two, three, four, five or six K;

(xxv) —SO 2 N(C 1 -C 6 alkyl) 2 , which C 1 -C 6 alkyl is, independently for each occurrence optionally substituted with one, two, three, four, five or six K;

(xxvi) —NHSO 2 (C 0 -C 6 alkyl), which C 1 -C 6 alkyl is optionally substituted with one, two, three, four, five or six K; and

(xxvii) —N(C 1 -C 6 alkyl)SO 2 (C 1 -C 6 alkyl), which C 1 -C 6 alkyl is, independently for each occurrence, optionally substituted with one, two, three, four, five or six K;

G is independently selected for each occurrence from the group consisting of:

(i) —H;

(ii) —halo;

(iii) —OH;

(iv) —C 1 -C 6 alkyl optionally substituted optionally substituted with one, two, three, four, five or six K;

(v) —OC 1 -C 6 alkyl optionally substituted with one, two, three, four, five or six K;

(vi) —SC 1 -C 6 alkyl optionally substituted with one, two, three, four, five or six K;

(vii) —NH(C 1 -C 6 alkyl), which C 1 -C 6 alkyl is optionally substituted with one, two, three, four, five or six K;

(viii) —N(C 1 -C 6 alkyl) 2 , which C 1 -C 6 alkyl is, independently for each occurrence, optionally substituted with one, two, three, four, five or six K;

(ix) —C 3 -C 5 cycloalkyl optionally substituted with one, two, three, four, five or six K; and

(x) 4 to 5 membered heterocyclyl optionally substituted with one, two, three, four, five or six K, which said 4 to 5 membered heterocyclyl comprises one or two heteroatoms independently selected for each occurrence from the group consisting of —N(J)-, —O— or —S—;

or two geminal G may, together with the carbon to which they are bound, form a —C 3 -C 5 cycloalkylene optionally substituted with one, two, three, four, five or six K or a 4 to 5 membered heterocyclylene optionally substituted with one, two, three, four, five or six K, wherein said 4 to 5 membered heterocyclylene comprises one heteroatom independently selected from the group consisting of —N(J)-, —O—, or —S—;

J is independently selected, for each occurrence, from the group consisting of:

(i) —H;

(ii) —C 1 -C 6 alkyl optionally substituted with one, two, three, four, five or six K;

(iii) —C(O)NH 2 ;

(iv) —C(O)NH(C 1 -C 6 alkyl), which C 1 -C 6 alkyl is optionally substituted with one, two, three, four, five or six K;

(v) —C(O)N(C 1 -C 6 alkyl) 2 , which C 1 -C 6 alkyl is, independently for each occurrence, optionally substituted with one, two, three, four, five or six K; and

(vi) —SO 2 (C 1 -C 6 alkyl), which C 1 -C 6 alkyl is optionally substituted with one, two, three, four, five or six halo; and

K is independently selected, for each occurrence, from the group consisting of —H, —F, —Cl, —OH, —CN, —CO 2 H, —CH 3 , —CH 2 CH 3 , —CH 2 F, —CHF 2 , —CF 3 , —CF 2 CF 3 , —OCH 3 , —OCH 2 F, —OCHF 2 , —OCF 3 , —SCH 3 , —SCH 2 F, —SCHF 2 , —SCF 3 —NH 2 , —NH(CH 3 ), —N(CH 3 ) 2 , and —CONH 2 .

2. A compound according to claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 3 is selected from the group consisting of —H, —F, —CH 3 , —CH 2 F, —CHF 2 , —CF 3 , —OCH 3 , —OCH 2 F, —OCHF 2 , and —OCF 3 .

3. A compound according to claim 2 , or a pharmaceutically acceptable salt thereof, wherein R 1 is selected from the group consisting of phenyl, thiophenyl, 1,4-dioxochromanyl, quinolinyl, pyrazolyl, indazolyl, pyridinyl, N-methyl-indazolyl and N-methyl-pyrazolyl.

4. A compound according to claim 3 , or a pharmaceutically acceptable salt thereof, wherein W is selected from the group consisting of —NHCG 2 -R 2 and —OCG 2 -R 2 .

5. A compound according to claim 4 , or a pharmaceutically acceptable salt thereof, wherein G is selected from the group consisting of —H; —C 1 -C 6 alkyl; methyl; —OC 1 -C 6 alkyl; and —C 3 -C 5 cycloalkyl; or two geminal G may, together with the carbon to which they are bound, form a —C 3 -C 5 cycloalkylene, cyclopropylene or cyclobutylene.

6. A compound selected from the group consisting of:

3-[(2-{[1-(pyrimidin-5-yl)cyclopropyl]amino}pyrimidin-5-yl)carbonyl]benzonitrile;

3-[(2-{[1-(pyridin-3-yl)cyclopropyl]amino}pyrimidin-5-yl)carbonyl]benzonitrile;

3-({2-[(2-phenylpropan-2-yl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

3-[(2-{[(2-aminopyrimidin-5-yl)methyl]amino}pyrimidin-5-yl)carbonyl]benzonitrile;

3-[(2-{[1-(pyrazin-2-yl)cyclopropyl]amino}pyrimidin-5-yl)carbonyl]benzonitrile;

3-[(2-{[(6-aminopyridin-3-yl)methyl]amino}pyrimidin-5-yl)carbonyl]benzonitrile;

3-[(2-{[1-(pyridin-3-yl)ethyl]amino}pyrimidin-5-yl)carbonyl]benzonitrile;

4-(1-{[5-(3-cyanobenzoyl)pyrimidin-2-yl]amino}ethyl)benzamide;

(−)-4-(1-{[5-(3-cyanobenzoyl)pyrimidin-2-yl]amino}ethyl)benzamide;

(+)-4-(1-{[5-(3-cyanobenzoyl)pyrimidin-2-yl]amino}ethyl)benzamide;

{2-[(pyrazin-2-ylmethyl)amino]pyrimidin-5-yl}[3-(trifluoromethyl)phenyl]methanone;

{2-[(pyridin-3-ylmethyl)amino]pyrimidin-5-yl}[3-(trifluoromethyl)phenyl]methanone;

[3-(methylsulfonyl)phenyl]{2-[(pyridin-3-ylmethyl)amino]pyrimidin-5-yl}methanone;

(3-methylphenyl){2-[(pyridin-3-ylmethyl)amino]pyrimidin-5-yl}methanone;

(2-fluorophenyl){2-[(pyridin-3-ylmethyl)amino]pyrimidin-5-yl}methanone;

(2-{[1-(pyrimidin-5-yl)cyclopropyl]amino}pyrimidin-5-yl)[3-(trifluoromethyl)phenyl]methanone;

[3-(methylsulfonyl)phenyl](2-{[1-(pyrimidin-5-yl)cyclopropyl]amino}pyrimidin-5-yl)methanone;

(3-methoxyphenyl)(2-{[1-(pyrimidin-5-yl)cyclopropyl]amino}pyrimidin-5-yl)methanone;

[3-(methylsulfonyl)phenyl]{2-[(pyrimidin-5-ylmethyl)amino]pyrimidin-5-yl}methanone;

[3-(methylsulfonyl)phenyl]{2-[(pyridazin-3-ylmethyl)amino]pyrimidin-5-yl}methanone;

(3,4-difluorophenyl){2-[(pyridin-3-ylmethyl)amino]pyrimidin-5-yl}methanone;

4-({[5-(3-methylbenzoyl)pyrimidin-2-yl]amino}methyl)benzamide;

[2-(benzylamino)pyrimidin-5-yl](3-chlorophenyl)methanone;

(3-chlorophenyl){2-[(2-phenylpropan-2-yl)amino]pyrimidin-5-yl}methanone;

3-({[5-(3-chlorobenzoyl)pyrimidin-2-yl]amino}methyl)benzonitrile;

3-{[2-(benzylamino)pyrimidin-5-yl]carbonyl}benzonitrile;

3-({2-[(4-chlorobenzyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

3-({2-[(4-methoxybenzyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

3-({2-[(2,4-difluorobenzyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

3-({2-[(4-fluorobenzyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

3-({2-[(2-chlorobenzyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

4-[({5-[3-(trifluoromethyl)benzoyl]pyrimidin-2-yl}amino)methyl]benzamide;

phenyl{2-[(pyridin-3-ylmethyl)amino]pyrimidin-5-yl}methanone;

[2-(benzylamino)pyrimidin-5-yl][3-(trifluoromethyl)phenyl]methanone;

(3-chlorophenyl){2-[(4-fluorobenzyl)amino]pyrimidin-5-yl}methanone;

{2-[(4-fluorobenzyl)amino]pyrimidin-5-yl}(3-methoxyphenyl)methanone;

(3-methylphenyl){2-[(pyridin-2-ylmethyl)amino]pyrimidin-5-yl}methanone;

(3-methylphenyl){2-[(pyridin-4-ylmethyl)amino]pyrimidin-5-yl}methanone;

[2-(benzylamino)pyrimidin-5-yl](3-methylphenyl)methanone;

(3,4-difluorophenyl){2-[(4-methoxybenzyl)amino]pyrimidin-5-yl}methanone;

4-({[5-(3-methylbenzoyl)pyrimidin-2-yl]amino}methyl)benzonitrile;

4-({[5-(3,4-difluorobenzoyl)pyrimidin-2-yl]amino}methyl)benzamide;

(3,4-difluorophenyl){2-[(2-phenylpropan-2-yl)amino]pyrimidin-5-yl}methanone;

[2-(benzylamino)pyrimidin-5-yl](3-methoxyphenyl)methanone;

{2-[(4-fluorobenzyl)oxy]pyrimidin-5-yl}[3-(trifluoromethyl)phenyl]methanone;

{2-[(4-chlorobenzyl)oxy]pyrimidin-5-yl}[3-(trifluoromethyl)phenyl]methanone;

3-({[5-(3-chlorobenzoyl)pyrimidin-2-yl]amino}methyl)benzamide;

4-({[5-(3,4-difluorobenzoyl)pyrimidin-2-yl]amino}methyl)benzoic acid;

4-[({5-[4-(trifluoromethyl)benzoyl]pyrimidin-2-yl}amino)methyl]benzonitrile;

{2-[(pyridin-3-ylmethyl)amino]pyrimidin-5-yl}[4-(trifluoromethyl)phenyl]methanone;

(4-chlorophenyl){2-[(4-fluorobenzyl)amino]pyrimidin-5-yl}methanone;

{2-[(4-methoxybenzyl)amino]pyrimidin-5-yl}(4-methoxyphenyl)methanone;

{2-[(4-fluorobenzyl)amino]pyrimidin-5-yl}[4-(trifluoromethyl)phenyl]methanone;

{2-[(4-methoxybenzyl)amino]pyrimidin-5-yl}[4-(trifluoromethyl) phenyl]methanone;

{2-[(pyridin-4-ylmethyl)amino]pyrimidin-5-yl}[3-(trifluoromethyl) phenyl]methanone;

{2-[(4-chlorobenzyl)amino]pyrimidin-5-yl}(4-chlorophenyl)methanone;

(2-{[4-(trifluoromethoxy)benzyl]amino}pyrimidin-5-yl)[3-(trifluoromethyl)phenyl]methanone;

4-({[5-(4-methoxybenzoyl)pyrimidin-2-yl]amino}methyl)benzamide;

(4-methoxyphenyl){2-[(pyridin-2-ylmethyl)amino]pyrimidin-5-yl}methanone;

{2-[(4-chloro-2-fluorobenzyl)amino]pyrimidin-5-yl}[3-(trifluoromethyl)phenyl]methanone;

3-[({5-[3-(trifluoromethyl)benzoyl]pyrimidin-2-yl}amino)methyl]benzonitrile;

(4-chlorophenyl){2-[(4-methoxybenzyl)amino]pyrimidin-5-yl}methanone;

3-({[5-(3-cyanobenzoyl)pyrimidin-2-yl]amino}methyl)benzonitrile;

3-({2-[(1-phenylcyclopropyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

{2-[(1-phenylcyclopropyl)amino]pyrimidin-5-yl}[3-(trifluoromethyl)phenyl]methanone;

{2-[(pyridazin-3-ylmethyl)amino]pyrimidin-5-yl}[3-(trifluoromethyl)phenyl]methanone;

4-({[5-(3-cyanobenzoyl)pyrimidin-2-yl]amino}methyl)benzamide;

5-[({5-[3-(trifluoromethyl)benzoyl]pyrimidin-2-yl}amino)methyl]pyridine-2-carboxamide;

5-[({5-[4-fluoro-3-(trifluoromethyl)benzoyl]pyrimidin-2-yl}amino)methyl]pyridine-2-carboxamide;

(2-{[1-(pyridin-3-yl)cyclopropyl]amino}pyrimidin-5-yl) [3-(trifluoromethyl)phenyl]methanone;

3-[(2-{[(2-oxo-1,2-dihydropyridin-4-yl)methyl]amino}pyrimidin-5-yl)carbonyl]benzonitrile;

(2-{[(6-methylpyridin-3-yl)methyl]amino}pyrimidin-5-yl)[3-(trifluoromethyl)phenyl]methanone;

[2-(benzylamino)pyrimidin-5-yl](4-methoxyphenyl)methanone;

(4-methoxyphenyl)(2-{[4-(trifluoromethoxy)benzyl]amino}pyrimidin-5-yl)methanone;

4-[({5-[3-(trifluoromethyl)benzoyl]pyrimidin-2-yl}amino)methyl]benzonitrile;

3-({[5-(4-methoxybenzoyl)pyrimidin-2-yl]amino}methyl)benzonitrile;

4-({2-[(4-fluorobenzyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

4-({2-[(4-methoxybenzyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

[4-fluoro-3-(trifluoromethyl) phenyl]{2-[(pyridin-2-ylmethyl)amino]pyrimidin-5-yl}methanone;

[4-fluoro-3-(trifluoromethyl) phenyl]{2-[(pyridin-3-ylmethyl)amino]pyrimidin-5-yl}methanone;

[4-fluoro-3-(trifluoromethyl) phenyl]{2-[(pyridin-4-ylmethyl)amino]pyrimidin-5-yl}methanone;

[2-(benzylamino)pyrimidin-5-yl][4-fluoro-3-(trifluoromethyl)phenyl]methanone;

4-[({5-[4-fluoro-3-(trifluoromethyl)benzoyl]pyrimidin-2-yl}amino)methyl]benzonitrile;

{2-[(4-fluorobenzyl)amino]pyrimidin-5-yl}[4-fluoro-3-(trifluoromethyl)phenyl]methanone;

4-[({5-[4-fluoro-3-(trifluoromethyl)benzoyl]pyrimidin-2-yl}amino)methyl]benzamide;

4-[({5-[4-fluoro-3-(trifluoromethyl)benzoyl]pyrimidin-2-yl}amino)methyl]benzoic acid;

[2-(benzylamino)pyrimidin-5-yl][3-fluoro-5-(trifluoromethyl)phenyl]methanone;

4-[({5-[3-fluoro-5-(trifluoromethyl)benzoyl]pyrimidin-2-yl}amino)methyl]benzonitrile;

4-[({5-[3-fluoro-5-(trifluoromethyl)benzoyl]pyrimidin-2-yl}amino)methyl]benzamide;

{2-[(4-fluorobenzyl)amino]pyrimidin-5-yl}[3-(methyl sulfonyl)phenyl]methanone;

[2-(benzylamino)pyrimidin-5-yl](2,3-dihydro-1,4-benzodioxin-6-yl)methanone;

2,3-dihydro-1,4-benzodioxin-6-yl{2-[(pyridin-3-ylmethyl)amino]pyrimidin-5-yl}methanone;

[2-(benzylamino)pyrimidin-5-yl](phenyl)methanone;

{2-[(pyridin-3-ylmethyl)amino]pyrimidin-5-yl}(thiophen-2-yl)methanone;

{2-[(2-fluorobenzyl)amino]pyrimidin-5-yl}(phenyl)methanone;

(2-chlorophenyl){2-[(pyridin-3-ylmethyl)amino]pyrimidin-5-yl}methanone;

(1-methyl-1H-pyrazol-4-yl){2-[(pyridin-3-ylmethyl)amino]pyrimidin-5-yl}methanone;

(2-methylquinolin-6-yl){2-[(pyridin-3-ylmethyl)amino]pyrimidin-5-yl}methanone;

5-({[5-(3-cyanobenzoyl)pyrimidin-2-yl]amino}methyl)pyridine-2-carboxamide;

4-{[(5-benzoylpyrimidin-2-yl)amino]methyl}benzamide;

5-{[(5-benzoylpyrimidin-2-yl)amino]methyl}pyridine-2-carboxamide;

3-({2-[(pyridazin-3-ylmethyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

phenyl{2-[(pyrimidin-5-ylmethyl)amino]pyrimidin-5-yl}methanone;

phenyl{2-[(2-phenylpropan-2-yl)amino]pyrimidin-5-yl}methanone;

phenyl{2-[(1-phenylcyclopropyl)amino]pyrimidin-5-yl}methanone;

3-({2-[(pyridazin-4-ylmethyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

3-{[(5-benzoylpyrimidin-2-yl)amino]methyl}benzonitrile;

phenyl(2-{[1-(pyridin-3-yl)cyclopropyl]amino}pyrimidin-5-yl)methanone;

phenyl{2-[(pyridazin-3-ylmethyl)amino]pyrimidin-5-yl}methanone;

phenyl{2-[(pyrazin-2-ylmethyl)amino]pyrimidin-5-yl}methanone;

3-({2-[(pyrazin-2-ylmethyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

3-({2-[(pyridin-3-ylmethyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

{2-[(pyrimidin-5-ylmethyl)amino]pyrimidin-5-yl}[3-(trifluoromethyl)phenyl]methanone;

3-({2-[(pyrimidin-5-ylmethyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

{2-[(2-phenylpropan-2-yl)amino]pyrimidin-5-yl}[3-(trifluoromethyl)phenyl]methanone;

{2-[(pyridazin-4-ylmethyl)amino]pyrimidin-5-yl}[3-(trifluoromethyl)phenyl]methanone;

3-({[5-(2,3-dihydro-1,4-benzodioxin-6-ylcarbonyl)pyrimidin-2-yl]amino}methyl)benzonitrile;

2,3-dihydro-1,4-benzodioxin-6-yl{2-[(2-phenylpropan-2-yl)amino]pyrimidin-5-yl}methanone;

4-[({5-[3-(methylsulfonyl)benzoyl]pyrimidin-2-yl}amino)methyl]benzamide;

4-[({5-[3-(methylsulfonyl)benzoyl]pyrimidin-2-yl}amino)methyl]benzonitrile;

{2-[(4-fluorobenzyl)amino]pyrimidin-5-yl}[3-fluoro-5-(trifluoromethyl)phenyl]methanone;

[3-fluoro-5-(trifluoromethyl) phenyl]{2-[(pyridin-3-ylmethyl)amino]pyrimidin-5-yl}methanone;

3-({2-[(1-phenylcyclobutyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

3-fluoro-5-({2-[(pyrimidin-5-ylmethyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

4-fluoro-3-({2-[(pyrimidin-5-ylmethyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

2-methyl-5-({2-[(pyrimidin-5-ylmethyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

3-[(2-{[1-(pyrimidin-5-yl)ethyl]amino}pyrimidin-5-yl)carbonyl]benzonitrile;

2-chloro-5-({2-[(pyrimidin-5-ylmethyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

2-fluoro-5-({2-[(pyrimidin-5-ylmethyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

3-({2-[(pyrimidin-5-ylmethyl)amino]pyrimidin-5-yl}carbonyl)benzamide;

(1-methyl-1H-indazol-6-yl){2-[(pyrimidin-5-ylmethyl)amino]pyrimidin-5-yl}methanone;

(4-methoxyphenyl)(2-{[1-(pyrimidin-5-yl)ethyl]amino}pyrimidin-5-yl)methanone;

{2-[(pyrimidin-5-ylmethyl)amino]pyrimidin-5-yl}[2-(trifluoromethyl)pyridin-4-yl]methanone;

(3-methoxyphenyl)(2-{[1-(pyrimidin-5-yl)ethyl]amino}pyrimidin-5-yl)methanone;

(3-methoxyphenyl){2-[(pyrimidin-5-ylmethyl)amino]pyrimidin-5-yl}methanone;

2,3-dihydro-1,4-benzodioxin-6-yl{2-[(pyrimidin-5-ylmethyl)amino]pyrimidin-5-yl}methanone;

3-chloro-5-[(2-{[1-(pyrimidin-5-yl)cyclopropyl]amino}pyrimidin-5-yl)carbonyl]benzonitrile;

3-[(2-{[1-(pyrazin-2-yl)cyclopropyl]amino}pyrimidin-5-yl)carbonyl]benzamide;

3-[(2-{[1-(pyrimidin-5-yl)cyclopropyl]amino}pyrimidin-5-yl)carbonyl]benzoic acid;

3-[(2-{[1-(pyrimidin-5-yl)cyclopropyl]amino}pyrimidin-5-yl)carbonyl]benzamide;

{3-[(2-{[1-(pyrimidin-5-yl)cyclopropyl]amino}pyrimidin-5-yl)carbonyl]phenyl}acetic acid;

3-[(2-{[1-(5-aminopyrazin-2-yl)cyclopropyl]amino}pyrimidin-5-yl)carbonyl]benzonitrile;

5-(1-{[5-(3-cyanobenzoyl)pyrimidin-2-yl]amino}cyclopropyl)pyridine-2-carboxamide;

3-[(2-{[1-(6-hydroxypyridin-3-yl)cyclopropyl]amino}pyrimidin-5-yl)carbonyl]benzonitrile;

(3-methoxyphenyl)(2-{[4-(4-methylpiperazin-1-yl)benzyl]amino}pyrimidin-5-yl)methanone;

[2-(benzyloxy)pyrimidin-5-yl][3-(trifluoromethyl)phenyl]methanone;

{2-[(2,4-difluorobenzyl)oxy]pyrimidin-5-yl}[3-(trifluoromethyl)phenyl]methanone;

{2-[(4-methoxybenzyl)oxy]pyrimidin-5-yl}[3-(trifluoromethyl)phenyl]methanone;

(2-{[4-(trifluoromethoxy)benzyl]oxy}pyrimidin-5-yl)[3-(trifluoromethyl)phenyl]methanone;

(1-methyl-1H-indazol-5-yl){2-[(pyrimidin-5-ylmethyl)amino]pyrimidin-5-yl}methanone;

4-(1-{[5-(4-methoxybenzoyl)pyrimidin-2-yl]amino}ethyl)benzamide;

2-methoxy-5-[(2-{[1-(pyrimidin-5-yl)cyclopropyl]amino}pyrimidin-5-yl)carbonyl]benzonitrile;

3-[(2-{[(4-hydroxycyclohexyl)methyl]amino}pyrimidin-5-yl)carbonyl]benzonitrile;

3-({2-[(tetrahydro-2H-pyran-4-ylmethyl)amino]pyrimidin-5-yl}carbonyl)benzonitrile;

3-[(2-{[(1-methylpiperidin-4-yl)methyl]amino}pyrimidin-5-yl)carbonyl]benzonitrile; and

(2-{[(1-ethylpyrrolidin-2-yl)methyl]amino}pyrimidin-5-yl)[3-(trifluoromethyl)phenyl]methanone;

or a pharmaceutically acceptable salt thereof.

7. A compound selected from the group consisting of: